Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-09-05

Clinical Trial Update: RiSolubles™, the Soluble Fraction of Rice Bran for HIV-Infected Patients [Phase 2]

View source ↗

Summary

Clinical trial update on RiSolubles™, the soluble fraction of rice bran, for HIV infection in a Phase 2 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RiSolubles

Snippet

Sponsor: Hadassah Medical Organization | Conditions: HIV Infections | Phase 2 | Status: UNKNOWN